Trial record 1 of 1 for:    NCT01691898
Previous Study | Return to List | Next Study

A Safety and Efficacy Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab (MabThera/Rituxan) or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab and Polatuzumab Vedotin Combined With Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (ROMULUS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Genentech, Inc.
Information provided by (Responsible Party):
Genentech, Inc. Identifier:
First received: September 16, 2012
Last updated: November 17, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: June 2019 (Final data collection date for primary outcome measure)